ResearcherAnhui Medical UniversityActive in the last 2 years

Meng Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-6089-2053; OpenAlex author ID A5021845436. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Enhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer. Last author DOI 10.1049/2024/9970665 ↗
Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. Co-author DOI 10.3892/ol.2019.10627 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Chen · 1 shared paper, 2024 · strength 0.31
- Paper Enhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer. DOI 10.1049/2024/9970665 ↗
Le Ren · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗
Yue Yu · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗
Fei Ding · 1 shared paper, 2019 · strength 0.12
- Paper Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. DOI 10.3892/ol.2019.10627 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.